Christopher Rhodes to Cyclic GMP
This is a "connection" page, showing publications Christopher Rhodes has written about Cyclic GMP.
Connection Strength
0.369
-
Therapeutic targets in pulmonary arterial hypertension. Pharmacol Ther. 2009 Jan; 121(1):69-88.
Score: 0.311
-
a1-A680T variant in GUCY1A3 as a candidate conferring protection from pulmonary hypertension among Kyrgyz highlanders. Circ Cardiovasc Genet. 2014 Dec; 7(6):920-9.
Score: 0.029
-
miR-21/DDAH1 pathway regulates pulmonary vascular responses to hypoxia. Biochem J. 2014 Aug 15; 462(1):103-12.
Score: 0.029